Gene · 80310
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy. | Stem Cell Res Ther | 2021 | 34863308 | PubTator, text mining | PubMed |
| A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer. | Front Immunol | 2021 | 34858395 | PubTator, text mining | PubMed |
| Prevalence of dermatofibrosarcoma protuberans in Saudi Arabia over 24 years.: A retrospective single-institution study. | Saudi Med J | 2021 | 34853143 | PubTator, text mining | PubMed |
| Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote Cholangiocarcinoma. | Cells | 2021 | 34831316 | PubTator, text mining | PubMed |
| Pulmonary Arterial Hypertension: A Deeper Evaluation of Genetic Risk in the -Omics Era. | Genes (Basel) | 2021 | 34828405 | PubTator, text mining | PubMed |
| Cholangiocarcinoma: what are the most valuable therapeutic targets - cancer-associated fibroblasts, immune cells, or beyond T cells? | Expert Opin Ther Targets | 2021 | 34806500 | PubTator, text mining | PubMed |
| Immunological perspective on the malignant progression of renal clear cell carcinoma. | Ann Transl Med | 2021 | 34790750 | PubTator, text mining | PubMed |
| Evaluation of breast cancer stem cells in human primary breast carcinoma and their role in aggressive behavior of the disease. | J Clin Transl Res | 2021 | 34778599 | PubTator, text mining | PubMed |
| The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors. | Int J Mol Sci | 2021 | 34768814 | PubTator, text mining | PubMed |
| Novel and Annotated Long Noncoding RNAs Associated with Ischemia in the Human Heart. | Int J Mol Sci | 2021 | 34768754 | PubTator, text mining | PubMed |
| Comprehensive quantitative characterization of the human term amnion proteome. | Matrix Biol Plus | 2021 | 34765964 | PubTator, text mining | PubMed |
| Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. | Environ Health Perspect | 2021 | 34747641 | PubTator, text mining | PubMed |
| MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery period. | Toxicology | 2021 | 34740672 | PubTator, text mining | PubMed |
| The Advances of Single-Cell RNA-Seq in Kidney Immunology. | Front Physiol | 2021 | 34721077 | PubTator, text mining | PubMed |
| Mesenchymal stem cells-derived exosomes for drug delivery. | Stem Cell Res Ther | 2021 | 34717769 | PubTator, text mining | PubMed |
| Integrins regulate stemness in solid tumor: an emerging therapeutic target. | J Hematol Oncol | 2021 | 34715893 | PubTator, text mining | PubMed |
| Periostin Exon-21 Antibody Neutralization of Triple-Negative Breast Cancer Cell-Derived Periostin Regulates Tumor-Associated Macrophage Polarization and Angiogenesis. | Cancers (Basel) | 2021 | 34680221 | PubTator, text mining | PubMed |
| Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro. | Cell Mol Biol Lett | 2021 | 34674640 | PubTator, text mining | PubMed |
| Dye-Mediated Photo-Oxidation Biomaterial Fixation: Analysis of Bioinductivity and Mechanical Properties of Bovine Pericardium for Use in Cardiac Surgery. | Int J Mol Sci | 2021 | 34639108 | PubTator, text mining | PubMed |
| Endostatin in fibrosis and as a potential candidate of anti-fibrotic therapy. | Drug Deliv | 2021 | 34595978 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80310/papers?page=24